Whether a child’s first HIV drug regimen is based on a protease inhibitor or a non-nucleoside reverse transcriptase inhibitor, treatment is likely to be equally effective, a researcher said here.
Whether a child’s first HIV drug regimen is based on a protease inhibitor or a non-nucleoside reverse transcriptase inhibitor, treatment is likely to be equally effective, a researcher said here.